Evotec offers integrated immune cell engager (ICE) discovery solutions that span from novel target identification to candidate selection, supporting the development of next-generation immunotherapies. Combining expertise in biologics, advanced in vitro biology, and translational assay systems, Evotec enables the design and optimization of bispecific and multi-specific engagers that precisely redirect immune cells toward disease targets. This end-to-end platform accelerates the discovery of high-quality therapeutic candidates, improving efficacy and enabling innovative approaches in immuno-oncology.